Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL251131 | 0.91 | EPHX1 (0.46) | EPHX1 | |
| SCHEMBL3377258 | 0.91 | EPHX1 (0.46) | EPHX1 | |
| SCHEMBL198224 | 0.91 | EPHX1 (0.46) | EPHX1 | |
| SCHEMBL3379488 | 0.89 | EPHX1 (0.42) | EPHX1 | |
| SCHEMBL3238806 | 0.88 | FAAH (0.39) | FAAHTRPV1 | |
| SCHEMBL3382030 | 0.84 | EPHX1 (0.39) | EPHX1 | |
| SCHEMBL7882701 | 0.83 | EPHX1 (0.38) | EPHX1 | |
| SCHEMBL7878188 | 0.83 | EPHX1 (0.38) | EPHX1 | |
| SCHEMBL503739 | 0.83 | EPHX1 (0.38) | EPHX1 | |
| SCHEMBL503916 | 0.83 | EPHX1 (0.38) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11654103-B2 | Skin care formulation | EMBRYOGENESIS PTY LTD | 2023-05-23 | — | — | US | claimed |
| US-20210330579-A1 | SKIN CARE FORMULATION | EMBRYOGENESIS PTY LTD (AU) | 2021-10-28 | — | — | US | claimed |
| US-20210322299-A1 | SKIN CARE FORMULATION | EMBRYOGENESIS PTY LTD (AU) | 2021-10-21 | — | — | US | claimed |
| EP-2490678-B1 | COATED CAPSULES AND TABLETS OF A FATTY ACID OIL MIXTURE | BASF AS (NO) | 2021-08-04 | — | — | EP | claimed |
| EP-2405902-B1 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A SURFACTANT, AND METHODS AND USES THEREOF | BASF AS (NO) | 2021-07-21 | — | — | EP | claimed |
| EP-2405895-B1 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE COMPRISING EPA AND DHA IN FREE ACID FORM AND A SURFACTANT, AND METHODS AND USES THEREOF | BASF AS (NO) | 2021-05-12 | — | — | EP | claimed |
| WO-2019164344-A1 | TEMPERATURE STABLE COMPOSITION FOR CONTROLLING PESTS AND METHOD FOR CONTROLLING PESTS USING SAME | 주식회사 엘지화학 | 2019-08-29 | — | — | WO | claimed |
| US-20190183781-A1 | SKIN CARE FORMULATION | EMBRYOGENESIS PTY LTD (AU) | 2019-06-20 | — | — | US | claimed |
| EP-3490572-A1 | SKIN CARE FORMULATION | Embryogenesis Pty Ltd (AU) | 2019-06-05 | — | — | EP | claimed |
| CN-109152800-A | Skin care formulation | 胚胎发育私人有限公司 | 2019-01-04 | — | — | CN | claimed |
| US-20020182868-A1 | Reduction of surface roughness during chemical mechanical planarization (CMP) | MICRON TECHNOLOGY, INC. | 2002-12-05 | — | — | US | claimed |
| US-6426295-B1 | Reduction of surface roughness during chemical mechanical planarization(CMP) | MICRON TECHNOLOGY, INC. | 2002-07-30 | — | — | US | claimed |
| EP-1014943-B1 | MEDICAL AEROSOL FORMULATIONS | JAGO RES AG (CH) | 2002-06-19 | — | — | EP | claimed |
| US-20020071818-A1 | Skin cleanser containing anti-aging active | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2002-06-13 | — | — | US | claimed |
| US-20020012695-A1 | Transdermal preparation containing hydrophilic or salt-form drug | PACIFIC CORPORATION (KR) | 2002-01-31 | — | — | US | claimed |
| EP-1163902-A2 | Transdermal preparation containing hydrophilic or salt-form drug | PACIFIC CORPORATION (KR) | 2001-12-19 | — | — | EP | claimed |
| WO-2001001949-A9 | CLEANSING COMPOSITIONS | JOHNSON & JOHNSON CONSUMER (US) | 2001-03-22 | — | — | WO | claimed |
| WO-2001001949-A1 | CLEANSING COMPOSITIONS | JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) | 2001-01-11 | — | — | WO | claimed |
| US-6054053-A | Methods of improving peak resolution in reversed-phase electrochromatography | BIO-RAD LABORATORIES, INC. (US) | 2000-04-25 | — | — | US | claimed |
| EP-0319455-A1 | Macroemulsion for preparing high density explosive compositions | ATLAS POWDER COMPANY (US) | 1989-06-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020071818-A1 | Skin cleanser containing anti-aging active | CUTA, POT1, DSG1 | EPHX1 2558/4885FAAH 338/4885TRPV1 2238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.